Global Pharmaceutical Excipients Market 2018-2023: Multifunctionality Excipients are Proving to Be Emerging Areas of New Product Development
Global Pharmaceutical Excipients Market 2018-2023: Multifunctionality Excipients are Proving to Be Emerging Areas of New Product Development
DUBLIN, April 19, 2018 /PRNewswire/ --
The "Pharmaceutical Excipients Market by Type (Organic chemical (Carbohydrate, Petrochemical), Inorganic chemical), Functionality (Filler, Coating, Disintegrant, Binder), Formulation (Tablet, Capsule, Topical, Parenteral) - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.
http://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
The global pharmaceutical excipients market is projected to reach USD 8.53 Billion by 2023 from USD 6.40 Billion in 2018, growing at a CAGR of 5.9%.
Factors such as the growing demand for pharmaceuticals due to the rising aging population and the incidence of chronic diseases, advancements in functional excipient development, growing generics market due to patent cliffs, rapidly growing biopharmaceuticals sector, emergence of multifunctional & co-processed excipients, and the growing biosimilars industry are driving the market growth.
The report analyzes the market by product, functionality, type of formulation, and region. Based on product, the organic chemical excipients segment accounted for the largest share of the market in 2017. This can be attributed to the use of these excipients in majorly all of the pharmaceutical formulations as they offer advantages such as increased efficacy in oral delivery of poorly soluble molecules along with increased compressibility and flowability properties.
Based on functionality, the pharmaceutical excipients market is segmented into fillers & diluents, binders, suspending & viscosity agents, flavoring agents & sweeteners, coating agents, colorants, disintegrants, lubricants & glidants, preservatives, emulsifying agents, and other functionalities. The large share of the fillers and diluents segment can be attributed to the increased use of fillers and diluents in the development and production of solid oral drugs. They improve the taste of the formulation and provide ease of administration (of the drug), along with offering stability, ease in preparation, packaging, shipping, and dispensing of drugs.
On the basis of type of formulation, the oral formulations segment dominated the market in 2017. The oral route of administration is the most common and traditional route for drug delivery. With the development of excipients to improve the functionality of active pharmaceutical ingredients (APIs) in tablets and capsules, the demand for these formulations is high. This in turn will also propel the market growth in the coming years.
The market is highly fragmented and competitive in nature and is dominated by Ashland (US), BASF (Germany), DowDuPont (US), Roquette (France), Evonik (Germany), Associated British Foods (UK), Archer Daniels Midland Company (US), Lubrizol (US), Croda (UK), Innophous Holdings (US), Kerry Group (Ireland), WACKER CHEMIE (Germany), and Signet (India).
Key players in the market are pursuing several organic and inorganic growth strategies such as product launches, expansions, acquisitions, and agreements to garner larger shares of the market. During 2014 to January 2018, companies adopted expansions as their major growth strategy followed by acquisitions.
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
4.1 Pharmaceutical Excipients: Market Overview
4.2 Pharmaceutical Excipients Market: Geographic Growth Opportunities
4.3 Regional Mix: Market (2018-2023)
4.4 Asia Pacific: Organic Chemical Excipients Market, By Type (2017)
4.5 Pharmaceutical Excipients Market: Developing vs Developed Markets
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Market Drivers
5.2.1.1 Growth of the Pharmaceuticals Market Backed By Functional Excipients
5.2.1.2 Surge in the Generics Market
5.2.1.3 Increasing Uptake of Biopharmaceuticals
5.2.2 Market Restraints
5.2.2.1 Cost and Time-Intensive Drug Development Process
5.2.2.2 Increasing Regulatory Stringency
5.2.3 Market Opportunities
5.2.3.1 Multifunctionality Excipients are Proving to Be Emerging Areas of New Product Development
5.2.3.2 Shifting Focus of Pharmaceutical Manufacturing to Emerging Countries
5.2.3.3 Growth in the Biosimilars Market
5.2.4 Market Challenges
5.2.4.1 Safety and Quality Concerns
6 Industry Insights
6.1 Introduction
6.2 Industry Trends
6.2.1 Rising Demand and Emphasis on Co-Processed Excipients
6.2.2 Improving Excipient Capabilities By Using Nanotechnology
6.2.3 Increasing Use of Direct Compression in Oral Dosage Formulations
6.3 Regulatory Analysis
6.3.1 North America
6.3.1.1 US
6.3.1.2 Canada
6.3.2 Europe
6.3.3 Asia Pacific
6.3.3.1 Japan
6.3.3.2 China
6.3.3.3 India
7 Pharmaceutical Excipients Market, By Product
7.1 Introduction
7.2 Organic Chemicals
7.2.1 Oleochemicals
7.2.1.1 Fatty Alcohols
7.2.1.2 Mineral Stearates
7.2.1.3 Glycerin
7.2.1.4 Other Oleochemical Excipients
7.2.2 Carbohydrates
7.2.2.1 Sugars
7.2.2.1.1 Actual Sugars
7.2.2.1.1.1 Lactose
7.2.2.1.1.2 Sucrose
7.2.2.1.1.3 Dextrose (D-Glucose)
7.2.2.1.2 Sugar Alcohols
7.2.2.1.2.1 Sorbitol
7.2.2.1.2.2 Mannitol
7.2.2.1.2.3 Other Sugar Alcohols
7.2.2.1.3 Artificial Sweeteners
7.2.2.2 Cellulose
7.2.2.2.1 Microcrystalline Cellulose
7.2.2.2.2 Cellulose Ethers
7.2.2.2.3 Cmc and Croscarmellose Sodium
7.2.2.2.4 Cellulose Esters
7.2.2.3 Starch
7.2.2.3.1 Modified Starch
7.2.2.3.2 Dried Starch
7.2.2.3.3 Converted Starch
7.2.3 Petrochemicals
7.2.3.1 Glycols
7.2.3.1.1 Polyethylene Glycol
7.2.3.1.2 Propylene Glycol
7.2.3.2 Povidones
7.2.3.3 Mineral Hydrocarbons
7.2.3.3.1 PetRoLAtum
7.2.3.3.2 Mineral Waxes
7.2.3.3.3 Mineral Oils
7.2.3.4 Acrylic Polymers
7.2.3.5 Other Petrochemical Excipients
7.2.4 Proteins
7.2.5 Other Organic Chemicals
7.3 Inorganic Chemicals
7.3.1 Calcium Phosphates
7.3.2 Metal Oxides
7.3.3 Halites
7.3.4 Calcium Carbonates
7.3.5 Calcium Sulfates
7.3.6 Other Inorganic Chemicals
7.4 Other Chemicals
8 Pharmaceutical Excipients Market, By Functionality
8.1 Introduction
8.2 Fillers & Diluents
8.3 Suspending & Viscosity Agents
8.4 Coating Agents
8.5 Binders
8.6 Flavoring Agents & Sweeteners
8.7 Disintegrants
8.8 Colorants
8.9 Lubricants & Glidants
8.10 Preservatives
8.11 Emulsifying Agents
8.12 Other Functionalities
9 Pharmaceutical Excipients Market, By Type of Formulation
9.1 Introduction
9.2 Oral Formulations
9.2.1 Tablets
9.2.2 Capsules
9.2.2.1 Hard Gelatin Capsules
9.2.2.2 Soft Gelatin Capsules
9.2.3 Liquid Formulations
9.3 Topical Formulations
9.4 Parenteral Formulations
9.5 Other Formulations
10 Pharmaceutical Excipients Market, By Region
11 Competitive Landscape
11.1 Overview
11.2 Market Share Analysis
11.2.1 Market Share Analysis: Global
11.2.2 Market Share Analysis: North America
11.2.3 Market Share Analysis: Europe
11.2.4 Market Share Analysis: Asia Pacific
11.3 Competitive Situation and Trends
12 Company Profiles
12.1 Dowdupont
12.2 Roquette
12.3 Ashland
12.4 BASF
12.5 Kerry
12.6 Evonik Industries
12.7 Croda
12.8 Associated British Foods
12.9 Archer Daniels Midland
12.10 Lubrizol
12.11 Innophos Holdings
12.12 Wacker Chemie
12.13 Signet
For more information about this report visit https://www.researchandmarkets.com/research/2hhmq4/global?w=5
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
View original content:http://www.prnewswire.com/news-releases/global-pharmaceutical-excipients-market-2018-2023-multifunctionality-excipients-are-proving-to-be-emerging-areas-of-new-product-development-300633127.html
SOURCE Research and Markets
